SMITH & NEPHEW PLC |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 986 GBX | -0.14% |
|
+0.69% | -8.61% |
| 08:56am | SMITH & NEPHEW : EPS cut (2023: +8.0%, 2024: -16.2%) |  |
| 05-14 | European Equities Traded in the US as American Depositary Receipts Nudge Higher in Tuesday Trading | MT |
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows:
- orthopedic surgery (39.9%): primarily orthopedic implants (hips, knees and shoulders);
- sports medicine, arthroscopy and cervicofacial surgery (31.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.;
- wound care (28.9%): skin grafts for major burns victims, treatments for leg ulcers, etc.
The United States accounts for 53.7% of net sales.
Calendar
24/07/2024
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
12.58
USD
Average target price
16.35
USD
Spread / Average Target
+29.92%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -8.61% | 10.97B | |
| +13.71% | 130B | |
| -3.55% | 8.42B | |
| +39.26% | 5.57B | |
| -24.12% | 4.59B | |
| +7.80% | 3.42B | |
| -11.14% | 2.73B | |
| -11.32% | 2.08B | |
| -13.47% | 1.92B | |
| -28.55% | 1.66B |
- Stock Market
- Equities
- SN. Stock
- News Smith & Nephew Plc
- New Smith & Nephew Chair to Take Office on Sept. 15
